Tylenol maker Kenvue faces mounting crisis after Trump’s rebuke
The US Food and Drug Administration has initiated the process for a label change to products containing acetaminophen that will say the ingredient is associated with a higher risk of autism in children when taken by pregnant women. It has also issued a related letter alerting physicians nationwide.

What's Your Reaction?






